Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Moderna Therapeutics
Moderna Therapeutics
Activities:
Research & Development
Cardiovascular
Digestion
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Moderna announces positive phase 1/2 data for vaccine against Covid-19
Moderna has shared positive phase 1/2 data for its breakthrough combination vaccine against Influenza and Covid-19
Research & Development
How serious is the Pirola strain?
Following the recent news of gradually increasing cases of the new COVID-19 variant Pirola, we sat down with Moderna's VP of Medical Affairs Cesar Sanz Rodriguez to discuss just what people can expect in the coming months
Distribution
Moderna receives positive opinion from the EMA for Spikevax
Moderna has revealed the European Medicine's Agency (EMA) has provided positive opinion on its COVID-19 vaccine Spikevax's marketing authorisation
Research & Development
Moderna discusses mRNA technology advances
Announcements on its mRNA tech, vaccine characterisation and biodistribution were made during the company’s Science and Technology Day event
Regulatory
Moderna senior executive to speak at the ISPE conference
As Chief Technical Operations and Quality Officer, Andres is responsible for the supply of products required for the company’s preclinical and clinical development programmes
Manufacturing
Moderna and Thermo Fisher sign long-term manufacturing agreement
Thermo Fisher will provide dedicated capacity for fill-finish services, in addition to inspection, labelling and packaging
Manufacturing
National Resilience to manufacture mRNA for Moderna vaccine
Under the terms of the multi-year agreement, Resilience will produce mRNA for the COVID-19 vaccine at its facility in Mississauga, Ontario in Canada
Subscribe now